The Spanish OTC and Consumer Health Market Market Entry Study for Foreign Suppliers of Branded and Private-Label Products A reference guide covering market size, key players, opportunities, market access requirements and a directory of importers and distribution partners Spain · OTC medicines · Food supplements · Medical devices · Dermocosmetics · Personal care Edition: October 2026
Table of Contents
1. Executive Summary.....................................................................................................................3
2. Market Definition and Scope........................................................................................................4
3. Market Size and Growth..............................................................................................................4
3.1 Growth drivers.......................................................................................................................5
3.2 Market constraints.................................................................................................................5
4. Market Structure and Distribution Channels................................................................................5
4.1 Community pharmacies........................................................................................................5
4.2 Pharmaceutical wholesale....................................................................................................6
4.3 Parapharmacy, perfumery and drugstore chains..................................................................6
4.4 Supermarkets and hypermarkets..........................................................................................6
4.5 Herbalists, dietetic and organic shops..................................................................................6
4.6 Online....................................................................................................................................6
5. Key Market Players......................................................................................................................7
6. Market Opportunities for New Foreign Suppliers.........................................................................7
6.1 Opportunities for branded products......................................................................................7
6.2 Opportunities for private-label and no-name suppliers.........................................................8
6.3 Entry routes compared..........................................................................................................8
7. Products and Product Groups with Strong Sales Potential.........................................................8
8. Market Access Requirements......................................................................................................9
8.1 Requirements by product category.....................................................................................10
8.2 Suppliers from the European Union....................................................................................10
8.3 Suppliers from non-EU Europe...........................................................................................11
8.4 Suppliers from outside Europe...........................................................................................11
8.5 Special territories and practical notes.................................................................................12
9. Directory of Importers and Distribution Partners.......................................................................12
9.1 Pharmaceutical full-line wholesalers and cooperatives......................................................12
9.2 Pharma and OTC companies that in-license and distribute foreign brands.......................14
9.3 Natural health, dietetic, parapharmacy and organic distributors........................................16
9.4 Drugstore, perfumery and discount chains.........................................................................16
9.5 Supermarket and hypermarket purchasing organisations..................................................18
9.6 Full-range FMCG and non-food importers..........................................................................20
9.7 Online pharmacies, e-commerce platforms and online specialists.....................................20
10. Market Entry Strategy and Recommendations........................................................................21
10.1 Recommended step-by-step approach.............................................................................21
10.2 What Spanish partners expect from foreign suppliers......................................................22
10.3 Trade fairs and industry events........................................................................................22
10.4 Typical pitfalls................................................................................................................... 22
11. Sources and Methodology.......................................................................................................22
11.1 Methodology..................................................................................................................... 22
11.2 Main sources.....................................................................................................................23
1. Executive Summary
Spain is one of the larger and more dynamic self-care markets in Europe. The consumer health market sold through Spanish community pharmacies (non-prescription medicines, self-care medical devices, food supplements, dermocosmetics, personal care and nutrition products) closed 2025 at more than EUR 7.6 billion at retail prices, growing by 3.7% and representing around 30% of the total pharmacy market. In the twelve months to March 2026 growth accelerated to 4.7%, with non-prescription medicines leading the trend. The total Spanish retail pharmacy market reached roughly EUR 26.9 billion in 2025 (+6.1%). On top of the pharmacy channel, significant consumer health volumes are sold through supermarkets and hypermarkets (food supplements, personal care, oral care, first aid), perfumery and drugstore chains, herbalists and organic shops (herbolarios, dietéticas) and a fast-growing online channel. These channels are not included in the pharmacy figures above, which means the total addressable market for non-medicine consumer health products is considerably larger. The market is attractive for foreign suppliers because it combines steady demand growth, an ageing population, a strong pharmacy culture, very high tourist inflows (sun care, travel health, digestive and cold products) and a well-organised wholesale structure that can deliver a new product to almost all of Spain’s roughly 22,000 pharmacies within hours. At the same time, the market is demanding: products must be fully compliant with EU and Spanish rules, labelled in Spanish, competitively priced and supported with pharmacy-level sales and marketing activity. Key conclusions for foreign suppliers: • Non-medicine categories offer the fastest entry. Food supplements, cosmetics/dermocosmetics and CE-marked self-care medical devices can be launched in months; OTC medicines require a Spanish (or EU) marketing authorisation and are best brought in through a licensing partner. • The pharmacy channel is the gatekeeper for credibility. Products that succeed in pharmacy can later expand into parapharmacy, online and grocery. Pharmacy wholesale is highly concentrated: the four largest full-line distributors (Cofares, Bidafarma, Hefame, Alliance Healthcare) together hold more than 70% of the market. • Private label is a real opportunity. Wholesaler brands (e.g. Cofares’ Farline and Aposán, Alliance’s Alvita), retailer brands (e.g. Mercadona’s Deliplus) and online pharmacy own brands are growing and source from qualified contract manufacturers, including foreign ones. • Distribution partners are the most common route for branded products. Spanish consumer health laboratories and specialist distributors regularly in-license foreign brands that are already successful in their home markets and provide the regulatory, marketing and pharmacy field-force infrastructure. • Market access differs by origin. EU suppliers benefit from free movement of goods and harmonised rules; suppliers from non-EU Europe (UK, Switzerland, Turkey, EEA) and from outside Europe need an EU-based responsible entity (importer, Responsible Person, Authorised Representative or Marketing Authorisation Holder) and must handle customs and, for medicines, EU batch release. Chapter 9 provides a structured directory of Spanish importers and distribution partners – full-line pharmaceutical wholesalers, consumer health laboratories that in-license brands, natural-health and parapharmacy distributors, drugstore and perfumery chains, grocery purchasing organisations, full-range FMCG importers and online platforms – together with the best available contact routes for a first approach.
Controlli mercato, settori e data di revisione prima dell'acquisto.
English